Showing results (171-180 of 184) with videos related to
Sort By:
Pageof 19
The American Journal of Gastroenterology|October 19, 2002
Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagusSteven R DeMeester, Kumari S Wickramasinghe, Reginald V N Lord, et al.Seminars in Cutaneous Medicine and Surgery|September 13, 2017
Atopic dermatitis: addressing allergy, infection, itch and complementary therapiesJusleen Ahluwalia, Dawn Marie Davis, Sharon Jacob, et al.Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphomaGregory S Ducker, Jonathan M Ghergurovich, Nello Mainolfi, et al.Cell Metabolism|February 19, 2019
Serine Metabolism Supports Macrophage IL-1β ProductionArianne E Rodriguez, Gregory S Ducker, Leah K Billingham, et al.The Journal of Clinical and Aesthetic Dermatology|July 22, 2026
Topical Prescription Therapy for Psoriasis: An Expert Position Paper on Limitations of Published Guidelines and Treatment Selection With Updated RecommendationsJoshua Burshtein, Danny Zakria, Tina Bhutani, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 30, 2025
Advances in Non-statin Lipid Therapies: A Narrative Review of Evolving Strategies for Cardiovascular Risk ReductionKayode Ogunniyi, Chukwuemeka Christian Aghasili, Olumide Akinmoju, et al.Integrated Environmental Assessment and Management|March 28, 2026
Building Tomorrow: Unlocking the Potential of Additive Manufacturing to Revolutionize Coastal InfrastructureAndrew McQueen, Alan J Kennedy, Burton Suedel, et al.Plos One|March 23, 2013
Genetic determinants of phosphate response in DrosophilaClemens Bergwitz, Mark J Wee, Sumi Sinha, et al.The Journal of Investigative Dermatology|March 11, 2015
Fidgetin-Like 2: A Microtubule-Based Regulator of Wound HealingRabab A Charafeddine, Joy Makdisi, David Schairer, et al.Journal of Drugs in Dermatology : JDD|September 21, 2018
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical TrialsAngela Moore, Lawrence J Green, Suzanne Bruce, et al.Pageof 19